The monograph covers the study of innovative development of one of the largest and knowledgeintensive sectors of the world economy — the pharmaceutical industry. It assesses the innovative activity of pharmaceutical companies in the global market, examines the market concentration in the industry and changing business-models within the largest multinationals. The author proposes an original methodology for assessing the level of innovation activity. On the example of the USA, EU and large developing countries the peculiarities of state regulation and the role of patenting are studied, the development strategies of pharmaceutical companies are analyzed, the prospects of scientific and technological development of the industry are assessed. The monograph includes the proposals for the innovation policy of Russia in the field of pharmaceuticals.

The work was recommended for publication by the dissertation council of IMEMO RAS based on the author's thesis for the degree of Candidate of Economic Sciences.